| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 52, 810-813, Copyright © 1981 by Endocrine Society
ARTICLES |
BL Salle, F Berthezene, FH Glorieux, EE Delvin, M Berland, L David, JP Varenne and G Putet
A pregnant woman suffering from idiopathic hypoparathyroidism was treated with calcitriol [0.5-2 micrograms/day 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3)]. Her twin infants were delivered by cesarian section at 37 weeks of gestation. Laboratory investigations in the perinatal period disclosed: 1) normal serum calcium and phosphorus levels in the mother, 2) normal babies with no clinical or biochemical signs of hyperparathyroidism, 3) a low serum level of 25-hydroxyvitamin D despite a normal serum level of 1,25-(OH)2D in the mother, and 4) a low level of 25-hydroxyvitamin D and a high level of 1,25-(OH)2D in cord serum in both infants. It is suggested that calcitriol is an effective treatment of hypoparathyroidism during pregnancy and produces no ill effects on the baby.
This article has been cited by other articles:
![]() |
B. L Salle, E. E Delvin, A. Lapillonne, N. J Bishop, and F. H Glorieux Perinatal metabolism of vitamin D Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1317S - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kovacs and H. M. Kronenberg Maternal-Fetal Calcium and Bone Metabolism During Pregnancy, Puerperium, and Lactation Endocr. Rev., December 1, 1997; 18(6): 832 - 872. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |